Cargando…
Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis
BACKGROUND: The primary treatment for advanced ovarian cancer is aggressive cytoreductive surgery (CRS), which is associated with considerable morbidity. The aim of this meta-analysis is to compare morbidity associated with primary CRS and secondary CRS for recurrent disease. METHODS: A literature s...
Autores principales: | Bartels, Helena C., Rogers, Ailin C., Postle, James, Shields, Conor, Mulsow, Jurgen, Conneely, John, Brennan, Donal J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693481/ https://www.ncbi.nlm.nih.gov/pubmed/31417960 http://dx.doi.org/10.1515/pp-2019-0014 |
Ejemplares similares
-
Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007) -
CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
por: Wang, Fang, et al.
Publicado: (2013) -
Efficacy of dexmedetomidine as an adjunct to ropivacaine in bilateral dual-transversus abdominis plane blocks in patients with ovarian cancer who underwent cytoreductive surgery
por: Zhang, Jian-ping, et al.
Publicado: (2022) -
Splenectomy during cytoreductive surgery in epithelial ovarian cancer
por: Sun, Hengzi, et al.
Publicado: (2018) -
Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer
por: Luna-Abanto, Jorge, et al.
Publicado: (2020)